These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 11072673

  • 1. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D, Rayes N, Bechstein WO, Naumann U, Neuhaus R, Berg T, Hopf U, Langrehr JM, Steinmüller T, Platz KP, Müller AR, Neuhaus P.
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [Abstract] [Full Text] [Related]

  • 2. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D, Rayes N, Neuhaus R, Berg T, Müller AR, Bechstein WO, Neuhaus P.
    Transpl Int; 2000 Sep; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [Abstract] [Full Text] [Related]

  • 3. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL, Trautwein C, Bock T, Böker KH, Jäckel E, Glowienka M, Oldhafer K, Bruns I, Gauthier J, Condreay LD, Raab HR, Manns MP.
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [Abstract] [Full Text] [Related]

  • 4. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
    Seehofer D, Rayes N, Naumann U, Neuhaus R, Müller AR, Tullius SG, Berg T, Steinmüller T, Bechstein WO, Neuhaus P.
    Transplantation; 2001 Oct 27; 72(8):1381-5. PubMed ID: 11685107
    [Abstract] [Full Text] [Related]

  • 5. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
    Seehofer D, Rayes N, Steinmüller T, Müller AR, Jonas S, Settmacher U, Neuhaus R, Berg T, Neuhaus P.
    Z Gastroenterol; 2002 Sep 27; 40(9):795-9. PubMed ID: 12215948
    [Abstract] [Full Text] [Related]

  • 6. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb 27; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 7. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D, Rayes N, Steinmüller T, Müller AR, Settmacher U, Neuhaus R, Radke C, Berg T, Hopf U, Neuhaus P.
    Liver Transpl; 2001 Nov 27; 7(11):976-82. PubMed ID: 11699034
    [Abstract] [Full Text] [Related]

  • 8. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    de Man RA, Bartholomeusz AI, Niesters HG, Zondervan PE, Locarnini SA.
    J Hepatol; 1998 Oct 27; 29(4):669-75. PubMed ID: 9824278
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL, Yuen MF, Hui CK, Garrido-Lestache S, Cheng CT, Lai YP.
    J Med Virol; 2002 Jul 27; 67(3):334-8. PubMed ID: 12116023
    [Abstract] [Full Text] [Related]

  • 10. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U, Paczek L, Foroncewicz B, Mucha K, Nyckowski P, Zieniewicz K, Ziarkiewicz-Wróblewska B, Ziółkowski J, Pilecki T, Patkowski W, Górnicka B, Paczkowska A, Krawczyk M.
    Ann Transplant; 2007 Jul 27; 12(3):28-32. PubMed ID: 18290567
    [Abstract] [Full Text] [Related]

  • 11. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
    Schiefke I, Klecker C, Maier M, Oesen U, Etzrodt G, Tannapfel A, Liebert UG, Berr F.
    Liver Int; 2004 Apr 27; 24(2):98-104. PubMed ID: 15078472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
    Shapira R, Daudi N, Klein A, Shouval D, Mor E, Tur-Kaspa R, Dinari G, Ben-Ari Z.
    Transplantation; 2002 Mar 15; 73(5):820-2. PubMed ID: 11907436
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
    Fontana RJ, Hann HW, Wright T, Everson G, Baker A, Schiff ER, Riely C, Anschuetz G, Riker-Hopkins M, Brown N, Lamivudine Compassionate Use Study Group.
    Liver Transpl; 2001 Jun 15; 7(6):504-10. PubMed ID: 11443577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
    Potthoff A, Tillmann HL, Bara C, Deterding K, Pethig K, Meyer S, Haverich A, Böker KH, Manns MP, Wedemeyer H.
    J Viral Hepat; 2006 Nov 15; 13(11):734-41. PubMed ID: 17052272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.